266428 osa 3 Ravimid tsefoksitiin, ipilimumab, okrelizumab ja immuunoglobuliin intravaskulaarseks kasutamiseks Roche Eesti OÜ
| Notice ID | 90cae844-20f3-4b31-910a-368e049dcf0a |
|---|---|
| Schema / form | eForms / ContractAwardNotice |
| Published | July 12, 2023 |
| Concluded | July 5, 2023 |
| Procedure | restricted |
| Contract / lot | 1.2-12/8948-1 / LOT-0003 |
| Type | supplies |
| Buyer | sihtasutus Põhja-Eesti Regionaalhaigla |
|---|---|
| CPV main | 33600000 |
| CPV extra | |
| Value | 108,000.00 EUR |
| Range low–high | – |
| Tenders received | (SME: ) |
Contractors (1)
| Name | Reg | Town | Country | SME? |
|---|---|---|---|---|
| Roche Eesti Osaühing | 11124024 | Tallinn | EE |